Page 75 - Amgen News Today

MCF Advisors LLC grew its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,162 shares of the medical research company’s stock after purchasing an additional 68 shares during the quarter. MCF […]

Capital Investment Advisory Services LLC decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,888 shares of the medical research company’s stock after selling 146 shares during the period. […]

MCF Advisors LLC grew its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 4,162 shares of the medical research company’s stock after acquiring an additional 68 shares during the period. MCF Advisors LLC’s holdings in Amgen were worth $1,199,000 at the end of […]

Something snapped on Wall Street this Friday: after five sessions of fairly steep declines in tech stocks, investors didnt come to pay for the lows as they usually do since the end of October.On the...

North Star Asset Management Inc. lifted its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 9,974 shares of the medical research company’s stock after acquiring an additional 40 shares during the quarter. North Star […]

As we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") moved to establish a multi-district litigation ("MDL") for its aflibercept BPCIA litigation...

For those interested in "buying the dip," this may be a good time to revisit the stock, noting the decline looks overdone in the short term.

Sage Mountain Advisors LLC boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 6.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,237 shares of the medical research company’s stock after buying an additional 208 shares during […]

BioPharma

Lee Danner & Bass Inc. trimmed its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 13.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,323 shares of the medical research company’s stock after selling 3,562 shares during the quarter. […]